Figure 1
From: Evidence of plasma biomarkers indicating high risk of dementia in cognitively normal subjects

Dot plot of measured levels of Aβ1–42 in the plasma of healthy control (HC), poststroke subjects (PS), individuals with a family history of Alzheimer’s disease (ADFH), and patients with end-stage renal disease (ESRD), obstructive sleep apnea (OSA) and Alzheimer’s disease (AD). *p < 0.05 and **p < 0.01 versus healthy control.